Download | < Back |
09 Feb 2017 | |
Ajanta Pharma Ltd has informed BSE that the Company's Paithan facility was recently inspected by US FDA and the Company has issued one procedural related 483. The Company is in process of responding to the same within the stipulated time prescribed by US FDA. | |
View all announcements for AJANTA PHARMA LTD. | Source: BSE India |